Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Anaptysbio (ANAB) Shares Outstanding (Weighted Average) (2016 - 2025)

Anaptysbio's Shares Outstanding (Weighted Average) history spans 10 years, with the latest figure at $28.8 million for Q4 2025.

  • For Q4 2025, Shares Outstanding (Weighted Average) rose 1.32% year-over-year to $28.8 million; the TTM value through Dec 2025 reached $28.8 million, up 1.32%, while the annual FY2025 figure was $28.8 million, 1.32% up from the prior year.
  • Shares Outstanding (Weighted Average) reached $28.8 million in Q4 2025 per ANAB's latest filing, up from $27.8 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $30.6 million in Q1 2025 to a low of $26.8 million in Q1 2024.
  • Average Shares Outstanding (Weighted Average) over 5 years is $27.8 million, with a median of $27.7 million recorded in 2022.
  • Peak YoY movement for Shares Outstanding (Weighted Average): decreased 4.41% in 2023, then rose 14.34% in 2025.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $27.4 million in 2021, then grew by 2.68% to $28.2 million in 2022, then fell by 4.41% to $26.9 million in 2023, then grew by 5.42% to $28.4 million in 2024, then increased by 1.32% to $28.8 million in 2025.
  • Per Business Quant, the three most recent readings for ANAB's Shares Outstanding (Weighted Average) are $28.8 million (Q4 2025), $27.8 million (Q3 2025), and $28.8 million (Q2 2025).